Serological Screening for Celiac Disease in Schoolchildren in Jordan. Is Height and Weight Affected when Seropositive?

Overview

Journal Ital J Pediatr

Publisher Biomed Central

Specialty Pediatrics

Date 2010 Feb 26

PMID 20181131

Citations 8

Authors

Mohamad K Nusier

Hedda Konstanse Brodtkorb

Siv Elisabeth Rein

Ahmed Odeh

Abdelrahman M Radaideh

Helge Klungland

Affiliations

Soon will be listed here.

Abstract

Background: Celiac disease (CD) emerged as a public health problem, and the disease prevalence varies among different races. The present study was designed to investigate the prevalence of CD using serological markers in apparently healthy schoolchildren in Irbid City, Jordan. Additionally, the effect of positive serology on height, weight and body mass index (BMI) was evaluated.

Methods: The study population consisted of 1985 children (1117 girls and 868 boys), age range was 5.5 to 9.5 years. Height and weight were measured and blood samples were collected from each individual. Serum samples were analyzed for IgA anti-tissue transglutaminase antibodies (tTG) using a commercial enzyme-linked immunosorbent assay (ELISA). tTG positive samples were further analyzed for IgA anti-endomysium antibodies (EmA) with a commercial ELISA. Samples confirmed positive with EmA were considered seropositive.

Results: Sixteen children were CD positive. The serological prevalence was estimated to be 1:124 (0.8%; 95% CI, 0.5% to 1.3%). Significant impact on growth (height) was found in seropositive children. When both sexes were individually analyzed, only boys showed height reduction. Furthermore, seropositive boys also had a significant weight reduction.

Conclusion: This study demonstrated that CD is prevalent among schoolchildren in Jordan. The seropositive children tend to have lower height, weight, and BMI than the seronegative group. These differences were significant only for boys. None of the participants is known to have CD prior to the study.

Citing Articles

Assessing the Impact of Celiac Disease on the Quality of Life in Jordan.

Haj-Ahmad L, Alqaisi A, Altamimi E Cureus. 2024; 16(11):e74395.

PMID: 39723263 PMC: 11669181. DOI: 10.7759/cureus.74395.

Humoral immune response to COVID-19 infection or vaccination among celiac disease patients.

Albatayneh E, Alabdallat Y, Kreishan E, Ayash H, Abu-Lubad M Cent Eur J Immunol. 2023; 47(3):267-274.

PMID: 36817269 PMC: 9896984. DOI: 10.5114/ceji.2022.118649.

Educational Intervention Improved Parental Knowledge, Attitudes, and Practices (KAP) and Adherence of Patients with Celiac Disease to Gluten-Free Diet.

Elsahoryi N, Altamimi E, Subih H, Hammad F, Woodside J Int J Food Sci. 2020; 2020:8850594.

PMID: 33015151 PMC: 7525320. DOI: 10.1155/2020/8850594.

Prevalence of celiac disease and celiac-related antibody status in pediatric patients with type 1 diabetes in Jordan.

Odeh R, Alassaf A, Gharaibeh L, Ibrahim S, Khdair Ahmad F, Ajlouni K Endocr Connect. 2019; 8(6):780-787.

PMID: 31085767 PMC: 6590199. DOI: 10.1530/EC-19-0146.

Celiac Disease in South Jordan.

Altamimi E Pediatr Gastroenterol Hepatol Nutr. 2018; 20(4):222-226.

PMID: 29302503 PMC: 5750376. DOI: 10.5223/pghn.2017.20.4.222.

References

Fasano A . Clinical presentation of celiac disease in the pediatric population. Gastroenterology. 2005; 128(4 Suppl 1):S68-73. DOI: 10.1053/j.gastro.2005.02.015. View

Fasano A, Berti I, Gerarduzzi T, Not T, Colletti R, Drago S . Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med. 2003; 163(3):286-92. DOI: 10.1001/archinte.163.3.286. View

Tommasini A, Not T, Kiren V, Baldas V, Santon D, Trevisiol C . Mass screening for coeliac disease using antihuman transglutaminase antibody assay. Arch Dis Child. 2004; 89(6):512-5. PMC: 1719951. DOI: 10.1136/adc.2003.029603. View

Fasano A . Should we screen for coeliac disease? Yes. BMJ. 2009; 339:b3592. DOI: 10.1136/bmj.b3592. View

Bingley P, Williams A, Norcross A, Unsworth D, Lock R, Ness A . Undiagnosed coeliac disease at age seven: population based prospective birth cohort study. BMJ. 2004; 328(7435):322-3. PMC: 338097. DOI: 10.1136/bmj.328.7435.322. View

Marine M, Fernandez-Banares F, Alsina M, Farre C, Cortijo M, Santaolalla R . Impact of mass screening for gluten-sensitive enteropathy in working population. World J Gastroenterol. 2009; 15(11):1331-8. PMC: 2658830. DOI: 10.3748/wjg.15.1331. View

Hill I, Dirks M, Liptak G, Colletti R, Fasano A, Guandalini S . Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2004; 40(1):1-19. DOI: 10.1097/00005176-200501000-00001. View

Harrison M, Wehbi M, Obideen K . Celiac disease: more common than you think. Cleve Clin J Med. 2007; 74(3):209-15. DOI: 10.3949/ccjm.74.3.209. View

Maki M, Mustalahti K, Kokkonen J, Kulmala P, Haapalahti M, Karttunen T . Prevalence of Celiac disease among children in Finland. N Engl J Med. 2003; 348(25):2517-24. DOI: 10.1056/NEJMoa021687. View

10.

Rawashdeh M, Khalil B, Raweily E . Celiac disease in Arabs. J Pediatr Gastroenterol Nutr. 1996; 23(4):415-8. DOI: 10.1097/00005176-199611000-00009. View

11.

Mearin M, Ivarsson A, Dickey W . Coeliac disease: is it time for mass screening?. Best Pract Res Clin Gastroenterol. 2005; 19(3):441-52. DOI: 10.1016/j.bpg.2005.02.004. View

12.

. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Nurs Ethics. 2005; 9(1):105-9. DOI: 10.1191/0969733002ne486xx. View

13.

Hopper A, Hadjivassiliou M, Hurlstone D, Lobo A, McAlindon M, Egner W . What is the role of serologic testing in celiac disease? A prospective, biopsy-confirmed study with economic analysis. Clin Gastroenterol Hepatol. 2008; 6(3):314-20. DOI: 10.1016/j.cgh.2007.12.008. View

14.

. Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child. 1990; 65(8):909-11. PMC: 1792502. DOI: 10.1136/adc.65.8.909. View

15.

Holt P, Tandy N, Anstee D . Screening of blood donors for IgA deficiency: a study of the donor population of south-west England. J Clin Pathol. 1977; 30(11):1007-10. PMC: 476624. DOI: 10.1136/jcp.30.11.1007. View

16.

Lundin K, Farstad I, Sollid L . [Coeliac disease--new clinical findings and diagnostic tools]. Tidsskr Nor Laegeforen. 2004; 123(22):3226-9. View

17.

Lovik A, Lundin K . [Dietary treatment of coeliac disease and dermatitis herpetiformis]. Tidsskr Nor Laegeforen. 2004; 123(22):3237-40. View

18.

West J, Logan R, Smith C, Hubbard R, Card T . Malignancy and mortality in people with coeliac disease: population based cohort study. BMJ. 2004; 329(7468):716-9. PMC: 518895. DOI: 10.1136/bmj.38169.486701.7C. View

19.

Hoffenberg E, Liu E . Celiac disease for the allergist: who and how to screen. Allergy Asthma Proc. 2007; 28(1):20-4. DOI: 10.2500/aap.2007.28.2945. View

20.

Hoffenberg E, Emery L, Barriga K, Bao F, Taylor J, Eisenbarth G . Clinical features of children with screening-identified evidence of celiac disease. Pediatrics. 2004; 113(5):1254-9. DOI: 10.1542/peds.113.5.1254. View